The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

M. Ducreux; G. K. Abou-Alfa; T. Bekaii-Saab; J. Berlin; A. Cervantes; T. de Baere; C. Eng; P. Galle; S. Gill; T. Gruenberger; K. Haustermans; A. Lamarca; P. Laurent-Puig; J. M. Llovet; F. Lordick; T. Macarulla; D. Mukherji; K. Muro; R. Obermannova; J. M. O'Connor; E. M. O'Reilly; P. Österlund; P. Philip; G. Prager; E. Ruiz-Garcia; B. Sangro; T. Seufferlein; J. Tabernero; C. Verslype; H. Wasan; E. Van Cutsem

doi:10.1016/j.esmoop.2023.101567

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

M. Ducreux, G. K. Abou-Alfa, T. Bekaii-Saab, J. Berlin, A. Cervantes, T. de Baere, C. Eng, P. Galle, S. Gill, T. Gruenberger, K. Haustermans, A. Lamarca, P. Laurent-Puig, J. M. Llovet, F. Lordick, T. Macarulla, D. Mukherji, K. Muro, R. Obermannova, J. M. O'ConnorE. M. O'Reilly, P. Österlund, P. Philip, G. Prager, E. Ruiz-Garcia, B. Sangro, T. Seufferlein, J. Tabernero, C. Verslype, H. Wasan, E. Van Cutsem

SYÖT, Syövänhoito

Tutkimustuotos: Katsausartikkeli › vertaisarvioitu

86 Sitaatiot (Scopus)

15 Lataukset (Pure)

Abstrakti

This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

Alkuperäiskieli	Englanti
Artikkeli	101567
Julkaisu	Esmo Open
Vuosikerta	8
Numero	3
DOI - pysyväislinkit	https://doi.org/10.1016/j.esmoop.2023.101567
Tila	Julkaistu - kesäk. 2023
OKM-julkaisutyyppi	A2 Katsausartikkeli tieteellisessä aikakauslehdessä

Julkaisufoorumi-taso

Jufo-taso 2

!!ASJC Scopus subject areas

Oncology
Cancer Research

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1016/j.esmoop.2023.101567Lisenssi: CC BY-NC-ND

1-s2.0-S2059702923007986-mainFinal published version, 318 KBLisenssi: CC BY-NC-ND

https://urn.fi/URN:NBN:fi:tuni-202306276929Lisenssi: CC BY-NC-ND

Siteeraa tätä

Ducreux, M., Abou-Alfa, G. K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J. M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., ... Van Cutsem, E. (2023). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. Esmo Open, 8(3), Artikkeli 101567. https://doi.org/10.1016/j.esmoop.2023.101567

@article{4515cc591ad34aa89e86ec4078974593,

title = "The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022",

abstract = "This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.",

keywords = "chemoembolisation, hepatocellular carcinoma, immunotherapy, liver transplantation, radioembolisation",

author = "M. Ducreux and Abou-Alfa, {G. K.} and T. Bekaii-Saab and J. Berlin and A. Cervantes and {de Baere}, T. and C. Eng and P. Galle and S. Gill and T. Gruenberger and K. Haustermans and A. Lamarca and P. Laurent-Puig and Llovet, {J. M.} and F. Lordick and T. Macarulla and D. Mukherji and K. Muro and R. Obermannova and O'Connor, {J. M.} and O'Reilly, {E. M.} and P. {\"O}sterlund and P. Philip and G. Prager and E. Ruiz-Garcia and B. Sangro and T. Seufferlein and J. Tabernero and C. Verslype and H. Wasan and {Van Cutsem}, E.",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = jun,

doi = "10.1016/j.esmoop.2023.101567",

language = "English",

volume = "8",

number = "3",

}

Ducreux, M, Abou-Alfa, GK, Bekaii-Saab, T, Berlin, J, Cervantes, A, de Baere, T, Eng, C, Galle, P, Gill, S, Gruenberger, T, Haustermans, K, Lamarca, A, Laurent-Puig, P, Llovet, JM, Lordick, F, Macarulla, T, Mukherji, D, Muro, K, Obermannova, R, O'Connor, JM, O'Reilly, EM, Österlund, P, Philip, P, Prager, G, Ruiz-Garcia, E, Sangro, B, Seufferlein, T, Tabernero, J, Verslype, C, Wasan, H & Van Cutsem, E 2023, 'The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022', Esmo Open, Vuosikerta 8, Nro 3, 101567. https://doi.org/10.1016/j.esmoop.2023.101567

TY - JOUR

T1 - The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

AU - Ducreux, M.

AU - Abou-Alfa, G. K.

AU - Bekaii-Saab, T.

AU - Berlin, J.

AU - Cervantes, A.

AU - de Baere, T.

AU - Eng, C.

AU - Galle, P.

AU - Gill, S.

AU - Gruenberger, T.

AU - Haustermans, K.

AU - Lamarca, A.

AU - Laurent-Puig, P.

AU - Llovet, J. M.

AU - Lordick, F.

AU - Macarulla, T.

AU - Mukherji, D.

AU - Muro, K.

AU - Obermannova, R.

AU - O'Connor, J. M.

AU - O'Reilly, E. M.

AU - Österlund, P.

AU - Philip, P.

AU - Prager, G.

AU - Ruiz-Garcia, E.

AU - Sangro, B.

AU - Seufferlein, T.

AU - Tabernero, J.

AU - Verslype, C.

AU - Wasan, H.

AU - Van Cutsem, E.

PY - 2023/6

Y1 - 2023/6

N2 - This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

AB - This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.

KW - chemoembolisation

KW - hepatocellular carcinoma

KW - immunotherapy

KW - liver transplantation

KW - radioembolisation

U2 - 10.1016/j.esmoop.2023.101567

DO - 10.1016/j.esmoop.2023.101567

M3 - Review Article

AN - SCOPUS:85160563203

SN - 2059-7029

VL - 8

JO - Esmo Open

JF - Esmo Open

IS - 3

M1 - 101567

ER -

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

Abstrakti

Julkaisufoorumi-taso

!!ASJC Scopus subject areas

YK:n kestävän kehityksen tavoitteet

Pääsy asiakirjaan

Sormenjälki

Siteeraa tätä